Patents by Inventor Jeri Janowsky

Jeri Janowsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Estrogen administration for treating male cognitive dysfunction or improving male cognitive function
    Publication number: 20060019938
    Abstract: Disclosed are methods of treating a male subject diagnosed with cognitive dysfunction that include administering an estrogenic agent, or a pharmaceutically acceptable salt or complex thereof, to the male subject. Also disclosed is a method of improving cognitive function in a hypogonadal male subject that includes transdermally administering to the male subject a therapeutically effective amount of an estrogenic agent, or a pharmaceutically acceptable salt or complex thereof. Further disclosed is a method of improving cognitive function in a male subject that includes administering to the male subject an estrogenic agent, or a pharmaceutically acceptable salt or complex thereof, at a dosage of about 0.025 to about 1.5 mg/day.
    Type: Application
    Filed: December 30, 2004
    Publication date: January 26, 2006
    Inventors: Tomasz Beer, Lisa Bland, Mark Garzotto, Jeri Janowsky
  • Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
    Patent number: 6596302
    Abstract: Methods for providing nutrition and for enhancing neurological development of preterm infants are disclosed. Also disclosed is an improved nutritional composition containing specified amounts of DHA and AA as well as their precursor essential fatty acids alpha-linolenic and linoleic acids. The methods involve feeding LCP supplemented, nutrient-enriched formulas for an extended feeding regimen, typically until at least 3 months corrected age (CA), preferably to 6 or even 12 months CA. The neurological developments, for example, visual development, motor development and language development were enhanced without findings of anthropometric growth faltering or inhibition.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: July 22, 2003
    Assignee: Abbott Laboratories
    Inventors: Deborah L. O'Connor, Nancy Auestad, Kathleen Fitzgerald-Gustafson, Robin Halter, Jeri Janowsky, Russell J. Merritt, Martha Neuringer, Lynn T. Singer
  • Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
    Publication number: 20020045660
    Abstract: Methods for providing nutrition and for enhancing neurological development of preterm infants are disclosed. Also disclosed is an improved nutritional composition containing specified amounts of DHA and AA as well as their precursor essential fatty acids alpha-linolenic and linoleic acids. The methods involve feeding LCP supplemented, nutrient-enriched formulas for an extended feeding regimen, typically until at least 3 months corrected age (CA), preferably to 6 or even 12 months CA. The neurological developments, for example, visual development, motor development and language development were enhanced without findings of anthropometric growth faltering or inhibition.
    Type: Application
    Filed: March 30, 2001
    Publication date: April 18, 2002
    Inventors: Deborah L. O'Connor, Nancy Auestad, Kathleen Fitzgerald-Gustafson, Robin Halter, Jeri Janowsky, Russell J. Merritt, Martha Neuringer, Lynn T. Singer